Clinical Trial Update: Immuno-Augmentation With GM-CSF of Pneumococcal Vaccine in Chronic Lymphocytic Leukemia Patients [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating GM-CSF immuno-augmentation of pneumococcal vaccination in patients with chronic lymphocytic leukemia; the study completed with…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia

Drugs mentioned

• Leukine (sargramostim)
• Pneumococcal vaccine (pneumococcal vaccine)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Leukemia | Phase 2 | Status: COMPLETED | Results posted: 2012-05-02